TRCT
TNON icon

Tower Research Capital (TRC)’s Tenon Medical TNON Stock Holding History

Tower Research Capital (TRC)’s Portfolio TNON Stock Details TNON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$299 Hold
26
– – ﹤0.01% 5076
2026
Q1 		$665 Buy
26
+22
+550% +$648 ﹤0.01% 4807
2025
Q4 		$128 Sell
4
-82
-95% -$3.3K ﹤0.01% 5027
2025
Q3 		$3.57K Buy
86
+13
+18% +$552 ﹤0.01% 4482
2025
Q2 		$2.49K Sell
73
-141
-66% -$5.4K ﹤0.01% 4642
2025
Q1 		$15.8K Buy
214
+172
+410% +$9.66K ﹤0.01% 3204
2024
Q4 		$2.75K Buy
42
+30
+250% +$3.08K ﹤0.01% 4779
2024
Q3 		$1.71K Sell
12
-15
-56% -$2.53K ﹤0.01% 5116
2024
Q2 		$4.59K Sell
27
-1
-4% -$212 ﹤0.01% 4763
2024
Q1 		$7.48K Buy
28
+10
+56% +$3.49K ﹤0.01% 4195
2023
Q4 		$8.07K Buy
+18
New +$8.81K ﹤0.01% 4547
2023
Q3 		– Sell
-1
Closed -$709 – 5651
2023
Q2 		$390 Sell
1
-1
-50% -$3.68K ﹤0.01% 5664
2023
Q1 		$9K Buy
2
+1
+100% +$5.53K ﹤0.01% 4547
2022
Q4 		$6K Hold
1
– – ﹤0.01% 4772
2022
Q3 		$3K Buy
+1
New +$5.83K ﹤0.01% 5428
2022
Q2 		– Hold
0
– – – 5865

Other funds holding TNON

WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SAMC
Spectrum Asset Management (California) Newport Beach, California $360M AUM 19.03% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Tower Research Capital (TRC)'s TNON Position: Q2 2026 in Review

Tower Research Capital (TRC) held its Tenon Medical (TNON) position steady in Q2 2026 at 26 shares worth $299. The position accounts for ﹤0.01% of the portfolio, ranked #5076.

Tower Research Capital (TRC) first reported a position in TNON in Q3 2022 and has held it in 15 quarters since. The position peaked at $15.8K in Q1 2025. 13 funds tracked by Wall St. Rank hold TNON as of Q2 2026.

  • Tower Research Capital (TRC) held 26 shares of Tenon Medical worth $299 as of Q2 2026.
  • Tower Research Capital (TRC) left its Tenon Medical share count unchanged in Q2 2026.
  • Tenon Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #5076 holding.
  • Tower Research Capital (TRC) first reported a position in Tenon Medical in Q3 2022 and has held it in 15 quarters since.
  • Tower Research Capital (TRC)'s Tenon Medical position peaked at $15.8K in Q1 2025.
  • 13 funds tracked by Wall St. Rank held Tenon Medical as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.